The FDA has not approved a stem-cell therapy specifically for primary immunodeficiency as a licensed product, though investigational protocols are registered with the NIH. Gene therapy has recently received FDA approval for select severe immunodeficiencies (ADA-SCID, Wiskott-Aldrich syndrome), representing an alternative to stem-cell therapy. Hematopoietic stem-cell transplantation from matched donors remains the FDA gold-standard definitive treatment for select immunodeficiencies. Patients considering experimental stem-cell therapy should discuss approved alternatives with immunologists before committing.
Primary immunodeficiency diseases encompass a heterogeneous group of inherited disorders affecting humoral immunity (B cells, antibody production), cellular immunity (T cells), complement, phagocytes, and innate immunity. Stem-cell research investigates whether fetal stem cells and placental mesenchymal stem cells can regenerate lymphoid tissue, promote T-cell and B-cell development within thymic or splenic niches, enhance phagocytic function, and restore immunological tolerance. With 91 registered trials and 13 currently recruiting, the biological rationale targets immune reconstitution through direct progenitor support and paracrine enhancement of developmental microenvironments. Early clinical data suggest potential for improving T-cell counts and function, enhancing antibody responses, reducing infection burden, and improving outcomes in severe combined immunodeficiency and other forms.
Am I a candidate? → · Primary Immunodeficiency: full overview → · Primary Immunodeficiency cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.
Evaluare medicală gratuită